出版物

2013

Randomized trial of preoperative docetaxel with or without capecitabine after 4 cycles of 5-fluorouracil–epirubicin–cyclophosphamide (FEC) in early-stage breast cancer: exploratory analyses identify Ki67 as a predictive biomarker for response to neoadjuvant chemotherapy

S. Ohno, L. W. C. Chow, N. Sato, N. Masuda, H. Sasano, F. Takahashi, H. Bando, H. Iwata, T. Morimoto, S. Kamigaki, T. Nakayama, S. Nakamura, K. Kuroi, K. Aogi, M. Kashiwaba, H. Yamashita, K. Hisamatsu, Y. Ito, Y. Yamamoto, T. Ueno, E. Fakhrejahani, N. Yoshida, M. Toi. Breast Cancer Research and Treatment, November 2013, Volume 142, Issue 1, pp 69-80  Details

Concurrent celecoxib with 5-fluorouracil/epirubicin/cyclophosphamide followed by docetaxel for stages II - III invasive breast cancer: the OOTR-N001 study

Chow LW, Tung SY, Ng TY, Im SA, Lee MH, Yip AY, Toi M, Glück S. Expert Opin Investig Drugs. 2013 Mar;22(3):299-307 ...[13-3-1]  Details

Randomized Phase III Placebo-Controlled Trial of Letrozole Plus Oral Temsirolimus As First-Line Endocrine Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer

Antonio C. Wolff, Ann A. Lazar, Igor Bondarenko, August M. Garin, Stephen Brincat, Louis Chow, Yan Sun, Zora Neskovic-Konstantinovic, Rodrigo C. Guimaraes, Pierre Fumoleau, Arlene Chan, Soulef Hachemi, Andrew Strahs, Maria Cincotta, Anna Berkenblit, Mizue Krygowski, Lih Lisa Kang, Laurence Moore, Daniel F. Hayes. J Clin Oncol. 2013 Jan 10;31(2):195-202. doi: 10.1200/JCO.2011.38.3331 ...[13-1-13]  Details

Changes of tumor infiltrating lymphocyte subtypes before and after neoadjuvant endocrine therapy in estrogen receptor-positive breast cancer patients - an immunohistochemical study of cd8+ and foxp3+ using double immunostaining with correlation to the pat

Chan MS, Wang L, Felizola SJ, Ueno T, Toi M, Loo W, Chow LW, Suzuki T, Sasano H. Int J Biol Markers. 2012 Dec 19:0. doi: 10.5301/JBM.2012.10439 ...[13-1-10]  Details

Evaluation of the psychological and biological changes of patients diagnosed with benign and malignant breast tumor

Bai LJ, Liu Q, Wang M, Loo WT, Cheng RW, Chow LW, Cheung MN, Wei KY, Yip AY, Ng EL. Int J Biol Markers. 2012 Nov 23:0. doi: 10.5301/JBM.2012.9936 ...[13-1-9]  Details

Correlation of epigenetic change and identification of risk factors for oral submucous fibrosis

Xu C, Zhao J, Loo WT, Hao L, Wang M, Cheung MN, Dou Y, Yip AY, Ng EL, Chow LW, Liu Q. Int J Biol Markers. 2012 Nov 23:0. doi: 10.5301/JBM.2012.9937 ...[13-1-9]  Details

The clinical trials of the Organisation for Oncology and Translational Research (OOTR)

Chow LW, Toi M. Int J Biol Markers. 2012 Dec 14:0. doi: 10.5301/JBM.2012.10371 ...[13-1-9]  Details

Prevention of oncological diseases: primary and secondary prevention

Chow LW, Yip AY, Ng EL. Int J Biol Markers. 2012 Dec 14:0. doi: 10.5301/JBM.2012.10370 ...[13-1-9]  Details

ootr.org

募集!! メンバーシップ

入会特典

学会登録割引

IJBM無料購読